Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Ashwagandha
Selected research topic
Digestion and gut health
The confirmed comparison studies tested several ingredients together. They cannot isolate the effect of this ingredient.
- Publications for this topic
- 1
- Human comparison publications
- 1
- Publications needing review
- 0
Findings in the studies
Patient Assessment of Constipation-Symptoms (PAC-SYM)
- Comparison result:A better result than the comparison group was reported.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
Combination studyMeasurement and study conditions
- Controlled human study
- Randomized trial
- Ingredient combination
- Unspecified population
- Outcome role not specified
- Between-group comparison
- Timepoint: unspecified
- Study comparison: unspecified
Representative outcome and study details
Human studies reported between-group improvement in Patient Assessment of Constipation-Symptoms (PAC-SYM).
combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · Population not specified · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
- Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 55.9 evidence score includes 6 independent human studies and 6 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 126
Papers linked to this topic 1 · distinct papers 1 · papers with a confirmed human comparison 1 · papers needing additional review 0
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- Patient Assessment of Constipation-Symptoms (PAC-SYM): Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
What the research found
Patient Assessment of Constipation-Symptoms (PAC-SYM)
The study reported improvement in this measurement.
Controlled study in people · Ingredient combination · Unspecified population
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Side effects reported with this ingredient alone
Symptoms or adverse events reported in studies without another active ingredient.
hepatotoxicity1 papers
The review indicates that Ashwagandha has inherent hepatotoxicity potential based on narrative review of liver toxicity of traditional Indian herbs.Human studies · Systematic reviewadverse effects1 papers
Ashwagandha has been associated with side effects and potential drug-herb interactions, though specific details are not quantified in this review.Human studies · Systematic review